Sun Pharmaceutical Industries Ltd. / Checkpoint Therapeutics, Inc.
2025 · Acquisition/Merger · $355M · Complete
Announcement Sentiment
96
Strongly positive
Sun Pharma agreed to acquire Checkpoint Therapeutics for $4.10/share cash plus CVR up to $0.70/share tied to EU approval milestones, total ~$355M. Deal brings UNLOXCYT, the first FDA-approved anti-PD-L1 treatment for advanced cSCC. Closed May 30, 2025.